BULLETIN V2025-1402
VAXIL BIO LTD. ("VXL")
BULLETIN TYPE: Consolidation
BULLETIN DATE: May 13, 2025
TSX Venture Tier 2 Company
Pursuant to a resolution passed by shareholders on March 31, 2025, the Company has consolidated its capital on a (50) old for (1) new basis. The name of the Company has not been changed.
Effective at the opening, Thursday, May 15, 2025, the common shares of Vaxil Bio Ltd. will commence trading on TSX Venture Exchange on a consolidated basis. The Company is classified as a 'Research and Development in the Life Sciences' company.
Post - Consolidation
Capitalization: Unlimited shares with no par value of which
2,739,579 shares are issued and outstanding
Escrow Nil shares are subject to escrow
Transfer Agent: Odyssey Trust Company
Trading Symbol: VXL (UNCHANGED)
CUSIP Number: 92243L206 (New)
_______________________________________
|
|
